Finally, sclerostin, the Wnt antagonist and the product of the sost gene that inhibits bone formation and plays a causal role in sclerosteosis, is transcriptionally activated by mef2c and is another osteocyte marker [29], [30]. Here, SOST is linked to sclerosteosis.